Member Info for alfista

Looks a decent appointment. "An exciting time in the company's development" suggests more expansion. Which will consume funds and trigger the usual detractor comments. Hey ho.

Yes, no significant extra news in this update. Fruitflow +O3 needs one more volume step to become cash generative IMHO. It has increased exposure now so there's reason to expect that.
Funding shouldn't be a huge challenge, this report does suggest assurance, although nothing is ever guaranteed.
News of events now would be a lot more use than those almost 6 months ago.

Don't know what to make of that geezer. Sworn enemy of AE, bezzy mate of AE. Big hugs on attention seeking charity walks.
Make yer mind up TW

For those keeping count.
92436

Click on the trades, it's just a tiny uncrossing trade.
Bid/Ask are still the same.

Not that difficult if you apply your mind to it.
Opening new markets is an investment. the original UK market is now in profit, that is being ploughed back to expansion of product range and market reach. Quite how you imagine any company on earth could achieve such sales growth without paying the execs along the way beggars belief.
Indeed, couldn't make it up

Guess it may depend what A trades are??

Hmm, that kinda flies in the face of the filings at CH for MMW doesn't it?
Surely Roxi would be generating substantial traffic, and revenues?

It's a shame that you always describe anyone talking in any way about a share that is so obviously not dead from an operational point of view as ramping. You know the language used by folks who do that, and it is far removed from any comment posted here.
Provexis ARE active, on several fronts. Trading is pretty much inactive, but if it becomes active, in either direction, then you can happily argue with the cheer leaders of that activity, because they'll be on for sure. Names who don't normally post here.

And you know it full well, so no need to abuse me.

What's enthusiastic about recognising reality.
Are in neutral, neither positive nor negative.
Gixer posted the relaunch of Qin drink in China, presumably a pause to rejig production to a larger scale. Also noted that there are more potential products due in other world markets. No sign of a decrease in enthusiasm from DSM.
All just simple reality. You live in a dark place, again presumably because you judged that you could buy in at any price and make an instant killing, others just observe facts.

Needless to say, I don't agree. Wellsite's friend has noted a further possible benefit, it is certainly worth raising with the scientists who continue to study and develop the IP for Fruitflow.

I haven't noticed either a rush for the exit, nor a new influx of investors enthused by the prospect of a major expansion of the colossal Chinese consumer market. My view is that we are increasingly likely to see the latter rather than the former.

Each to their own

Never seen any studies done on arthritis, but logic suggests that better bloodflow could have beneficial affects on almost all of the body. Is it an inflammation type illness? In which case Fruitflow has been shown as having an effect. Might be worth querying it with Mr Ford

Interesting that this Magic Media doesn't appear to be doing anything, and has no person or entity registrable as being in control. How does that fit with their claim to only invest in cash generating businesses run by trusted entrepreneurs?

Just a tangled mess of non active companies.
Go figure.

If you've researched this company, you'll know that this is usually an investment rather than a speculation, although volatility has been higher recently. For holders, the spread is of no significance, rather the debt reduction, company growth, and increasing dividend yield.

Each to their own

OK,
So, on what basis did you choose to buy what you did, when you did?
And also to sell what you did, when you did.
Seem fair questions to me.

Totally unreadable. Perhaps there should be a Narcissists Tab provided

Have you ever chatted with IF Gix?

Bid

Did and Ask are exactly the same.
A very small A trade is all it takes to dupe some isn't it.
Look at actual trades before growling.

Even the most elementary analysis tells us that a turnover of many multiples of the current level changes the company's fortunes totally.

Maybe there would be increased spend on admin, or on marketing for Provexis retail, and increased spending to fully develop all health claims. Despite that, the underlying profitability would be hard to deny, and would become actual; distributable profit over time.
Personally, I don't care how much gain those with options make, I know for sure that the firm intention is to achieve the maximum for all investors.

The risk to getting Blue Cap status is the involvement of "waiguoran" (foreign) participants. A company the size of By Health should have enough clout to overcome that, and thereby start to give us a more realistic valuation of Fruitflow as a global health benefitting product.
IMHO